Egypt Today: Under the leadership of Chairperson Ali Ghamrawy, the Egyptian Drug Authority (EDA) recently held discussions with a senior delegation from global pharmaceutical company Sandoz to explore ways to localize the production of oncology drugs in Egypt.
The meeting was centered around Sandoz's expansion plans in the Egyptian market and the strengthening of its partnership with the EDA.
Key topics included the local manufacturing of oncology treatments, the growing importance of biosimilars in the region, and a thorough review of the sector’s current opportunities and challenges.
Ghamrawy and the delegation outlined a joint vision aimed at fostering innovation and improving access to advanced treatments, which would contribute to both the Egyptian healthcare system’s growth and the nation’s drug security. Ghamrawy reaffirmed the EDA’s dedication to facilitating investment, particularly in the field of pharmaceutical localization.
Noting the substantial progress in Egypt's regulatory framework and digital infrastructure, Ghamrawy stressed that the EDA continues to provide essential support to industry players. This includes aligning with the Egyptian government’s objectives of boosting pharmaceutical localization and export potential.
The discussions are in line with Sandoz’s broader commitment to enhancing local manufacturing capabilities in Egypt, which supports the government’s goal of achieving self-sufficiency in the production of vital medicines.
Egypt has struggled with a shortage of medicines for over a year now, triggered by rising production costs, foreign currency shortages, and stranded imports at ports. To combat the shortage, the government implemented several initiatives to ease customs and facilitate medical imports, as well as promote localizing the industry.
Recent efforts to localize the pharmaceutical industry include meetings with Kuwait-based Ali Alghanim & Sons Group, and a Arab Company for Drug Industries-led consortium looking to establish a raw pharmaceutical materials factory.
https://www.egypttoday.com/Article/3/138623/Egyptian-Drug-Authority-pharmaceutical-company-Sandoz-talk-localizing-oncology-medicine
